Welcome

 
home_1

"New Wockhardt: new way of thinking..."

The concept is inspired by two related thoughts. Wockhardt is a business in transition. It has achieved international scale and is now positioned to begin a new and exciting phase of its growth journey. At the same time, the world is changing and old orders are giving way to new hierarchies.

New and innovative business models are required if companies are to make the most of emerging opportunities. We are making a paradigm shift – replacing the old and embracing the new. Innovation is the heartbeat of Wockhardt. It goes beyond innovative product development and includes the development of innovative new business models. This is how we meet the changing needs and expectations of the customers we serve.

During the past year there has been a focus within Wockhardt of looking for new ways of thinking, new ways of working and new ways to touch people's lives.

Learn more...

About Us
News & Events
View Wockhardt Video - "One World - One Quality"

 
 
 

Products

 
home_2

"Offering a generic and branded pharmaceutical portfolio of over 220 NDCs spanning 75 different product families"

Four product launches in 2011 include Donepezil HCI tablets, Levofloxacin tablets, Pantoprozole Sodium DR tablets, and Venlafaxine ER capsules.

Three additional product launches anticipated for 4Q2011.

Vertical integration of products with manufacturing in the USA, Europe and India.

Learn more...


Products

Shellpak® Info
 
 
 

Knowledge Center

 
home_3

"Did you know...?"

...that effective March 31, 2008, the FDA has directed companies to stop making and distributing any unapproved drug products containing hydrocodone, including cough suppressants and pain relievers.
Morton Grove offers several FDA-approved pediatric cough and cold products.

Learn more...

FDA steps up its efforts against unapproved drugs

Generic drugs make up 77.8% of all prescriptions dispensed in the US4

 
  2011, Wockhardt USA, All Rights Reserved
Legal Disclaimer    |    Terms of Use    |    Privacy Policy